Circulating Tumor Cells in metastatic Breast Cancer

被引：0

作者：

Krawczyk, Natalia ^{[1
]}

Meier-Stiegen, Franziska ^{[1
]}

Katzorke, Nora ^{[1
]}

Janni, Wolfgang ^{[2
]}

Mueller, Volkmar ^{[3
]}

Rack, Brigitte ^{[4
]}

Fasching, Peter ^{[5
]}

Wallwiener, Diethelm ^{[6
]}

Albrecht, Susanne ^{[2
]}

Fehm, Tanja ^{[1
]}

机构：

[1] Univ Frauenklin Dusseldorf, Dusseldorf, Germany

[2] Univ Frauenklin Ulm, Ulm, Germany

[3] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Gynakol, Hamburg, Germany

[4] LMU Munchen, Klin & Poliklin Frauenheilkunde & Geburtshife, Munich, Germany

[5] Univ Klinikums Erlangen, Frauenklin, Erlangen, Germany

[6] Univ Frauenklin Tubingen, Tubingen, Germany

来源：

GEBURTSHILFE UND FRAUENHEILKUNDE | 2014年 / 74卷 / 11期

关键词：

BONE-MARROW; HER2; STATUS; SURVIVAL; PROGRESSION; THERAPY;

D O I：

10.1055/s-0034-1368644

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：986 / 988

页数：3

共 16 条

[1] Circulating Tumor Cells: Liquid Biopsy of Cancer [J].

Alix-Panabieres, Catherine ;

Pantel, Klaus .

CLINICAL CHEMISTRY, 2013, 59 (01) :110-118

[2] The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer [J].

Banys, Malgorzata ;

Krawczyk, Natalia ;

Becker, Sven ;

Jakubowska, Jolanta ;

Staebler, Annette ;

Wallwiener, Diethelm ;

Fehm, Tanja ;

Rothmund, Ralf .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) :121-129

[3] Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer [J].

Bernhard, Helga ;

Neudorfer, Julia ;

Gebhard, Kerstin ;

Conrad, Heinke ;

Hermann, Christine ;

Naehrig, Joerg ;

Fend, Falko ;

Weber, Wolfgang ;

Busch, Dirk H. ;

Peschel, Christian .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (02) :271-280

[4] Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer [J].

Bozionellou, V ;

Mavroudis, D ;

Perraki, M ;

Papadopotilos, S ;

Apostolaki, S ;

Stathopoulos, E ;

Stathopoulou, A ;

Lianidou, E ;

Georgoulias, V .

CLINICAL CANCER RESEARCH, 2004, 10 (24) :8185-8194

[5] A pooled analysis of bone marrow micrometastasis in breast cancer [J].

Braun, S ;

Vogl, FD ;

Naume, B ;

Janni, W ;

Osborne, MP ;

Coombes, RC ;

Schlimok, G ;

Diel, IJ ;

Gerber, B ;

Gebauer, G ;

Pierga, JY ;

Marth, C ;

Oruzio, D ;

Wiedswang, G ;

Solomayer, EF ;

Kundt, G ;

Strobl, B ;

Fehm, T ;

Wong, GYC ;

Bliss, J ;

Vincent-Salomon, A ;

Pantel, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (08) :793-802

[6] Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer [J].

Budd, G. Thomas ;

Cristofanilli, Massimo ;

Ellis, Mathew J. ;

Stopeck, Allison ;

Borden, Ernest ;

Miller, M. Craig ;

Matera, Jeri ;

Repollet, Madeline ;

Doyle, Gerald V. ;

Terstappen, Leon W. M. M. ;

Hayes, Daniel F. .

CLINICAL CANCER RESEARCH, 2006, 12 (21) :6403-6409

[7] Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].

Cristofanilli, M ;

Budd, GT ;

Ellis, MJ ;

Stopeck, A ;

Matera, J ;

Miller, MC ;

Reuben, JM ;

Doyle, GV ;

Allard, WJ ;

Terstappen, LWMM ;

Hayes, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791

[8] ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients [J].

Fehm, Tanja ;

Krawczyk, Natalia ;

Solomayer, Erich-Franz ;

Becker-Pergola, Graziella ;

Duerr-Stoerzer, Silke ;

Neubauer, Hans ;

Seeger, Harald ;

Staebler, Annette ;

Wallwiener, Diethelm ;

Becker, Sven .

BREAST CANCER RESEARCH, 2008, 10 (05)

[9] Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment [J].

Giuliano, Mario ;

Giordano, Antonio ;

Jackson, Summer ;

Hess, Kenneth R. ;

De Giorgi, Ugo ;

Mego, Michal ;

Handy, Beverly C. ;

Ueno, Naoto T. ;

Alvarez, Ricardo H. ;

De Laurentiis, Michelino ;

De Placido, Sabino ;

Valero, Vicente ;

Hortobagyi, Gabriel N. ;

Reuben, James M. ;

Cristofanilli, Massimo .

BREAST CANCER RESEARCH, 2011, 13 (03)

[10] Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival [J].

Hayes, Daniel F. ;

Cristofanilli, Massimo ;

Budd, G. Thomas ;

Ellis, Matthew J. ;

Stopeck, Alison ;

Miller, M. Craig ;

Matera, Jeri ;

Allard, W. Jeffrey ;

Doyle, Gerald V. ;

Terstappen, Leon W. W. M. .

CLINICAL CANCER RESEARCH, 2006, 12 (14) :4218-4224

← 1 2 →